Niklas Bergh is a Senior Medical Director in Early Clinical Development for Cardiovascular, Renal, and Metabolism at AstraZeneca in Gothenburg, Sweden. With a robust background in cardiology, they served as a Kardiolog at Sahlgrenska University Hospital from 2006 to 2022 and held the position of Sektionschef, Överläkare during their final year there. They have also been involved in leadership roles, including Chief Executive Officer at Cereno Scientific AB from 2013 to 2015 and serving on various boards since 2010. Niklas remains active in academia as a Docent at Göteborgs universitet, where they earned both a Doctor of Medicine and a Läkarexam in medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices